doxazosin has been researched along with piperidines in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chai, CY; Chen, IJ; Chou, YH; Huang, CH; Liu, CM; Lo, YC; Tai, MH; Wu, BN; Wu, WJ | 1 |
| El Sharkawi, FZ; El Shemy, HA; Khaled, HM | 1 |
2 other study(ies) available for doxazosin and piperidines
| Article | Year |
|---|---|
Piperazine-designed alpha 1A/alpha 1D-adrenoceptor blocker KMUP-1 and doxazosin provide down-regulation of androgen receptor and PSA in prostatic LNCaP cells growth and specifically in xenografts.
Topics: Adrenergic alpha-Antagonists; Animals; bcl-2-Associated X Protein; Cell Division; Down-Regulation; Doxazosin; Enzyme-Linked Immunosorbent Assay; Humans; Male; Mice; Mice, Nude; Piperidines; Prostate-Specific Antigen; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Receptors, Androgen; Reverse Transcriptase Polymerase Chain Reaction; Transplantation, Heterologous; Xanthines | 2009 |
Possible anticancer activity of rosuvastatine, doxazosin, repaglinide and oxcarbazepin.
Topics: Animals; Anticonvulsants; Antihypertensive Agents; Antineoplastic Agents; Carbamates; Carbamazepine; Carcinoma, Ehrlich Tumor; Cell Proliferation; Cell Survival; Doxazosin; Fluorobenzenes; HeLa Cells; Hep G2 Cells; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Inhibitory Concentration 50; MCF-7 Cells; Oxcarbazepine; Piperidines; Pyrimidines; Rosuvastatin Calcium; Sulfonamides | 2014 |